The nation of Zimbabwe has rejected a substantial American healthcare agreement worth 367 million US dollars (£272m) over five years because of Washington's request for sensitive data.
This move came to light after a official document dated December was disclosed, indicating that President Emmerson Mnangagwa deemed the arrangement was "skewed".
An official spokesperson later clarified that the United States was seeking biological samples for research and commercial gain but was unwilling to guarantee the resulting advantages from future vaccines.
"We are forced to start the challenging and unfortunate process of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had furnished over $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for continued talks to find a deal acceptable to both sides so the nation's vital HIV programme can proceed.
Wider Context
This rejection follows a comparable situation in neighbouring Kenya, where a court halted a related health funding agreement following legal challenges were raised about the security of citizens' medical information.
Since returning to the presidency recently, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
USAID had managed assistance for the US government, but Trump argued its spending was "inefficient" and his administration was pursuing government-to-government deals to enhance transparency and responsibility.
As per statements, 16 African countries have to date signed similar agreements, constituting more than $18.3bn of fresh investment.
Details of the Rejected Deal
The money for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We believe this collaboration could have provided extraordinary advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently on antiretroviral therapy through US-supported initiatives," Tremont commented.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"The proposal required Zimbabwe to share its genetic material and health information for a long time, without any equivalent promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.
"Put simply, our country would provide the basic resources for medical research without any assurance that the end products would be available to our citizens if a future disease outbreak arise."
National Interest and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its pursuit of bilateral deals were upending systems previously established via the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing system created to manage future global health emergencies.
"This system is designed to guarantee that when a country provides its data, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised solely by those with the capability to develop them."
These objections over the US deal "should not be misconstrued as opposition to America," he added.
"We welcome continued dialogue with our American counterparts on how subsequent collaboration might be structured in a way that respects the sovereignty and interests of each country."
Medical Community Response
A leading public health body expressed it recognised the government's concerns, but recommended that negotiations need to persist considering a large portion of the country's HIV programmes depended on foreign aid.
"In cases where technical issues arise, such as those involving data governance or implementation frameworks, these can often be resolved through technical clarification and negotiated safeguards," the group commented.
The situation highlights the complex debate between accepting vital international aid and safeguarding a country's data in an increasingly interconnected world.